400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Anti-infection / HCV / GSK2236805/Gsk-2336805游离态
CAS No.: 1256390-53-0
Synonyms: GSK-805;JNJ-56914845
GSK-2336805 is a HCV NS5A inhibitor potentially for the treatment of HCV infection.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT01724086 | Chronic Hepatitis C | Phase 2 | Completed | - | Belgium ... more >> Antwerpen, Belgium Brugge, Belgium Brussels, Belgium Edegem, Belgium Gent, Belgium Leuven, Belgium Liège, Belgium Germany Berlin, Germany Hamburg, Germany Mainz, Germany Collapse << |
NCT02018536 | Healthy | Phase 1 | Completed | - | United States, California ... more >> Cypress, California, United States Collapse << |
NCT01424540 | Hepatitis C | Phase 1 | Completed | - | United States, New York ... more >> GSK Investigational Site Buffalo, New York, United States, 14202 Collapse << |
实验方案
技术信息
CAS号 | 1256390-53-0 | 储存条件 |
|
|
分子式 | C42H52N8O8 | 运输 | 蓝冰 | |
分子量 | 796.91 | 别名 | GSK-805;JNJ-56914845 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT01724086 | Chronic Hepatitis C | Phase 2 | Completed | - | Belgium ... more >> Antwerpen, Belgium Brugge, Belgium Brussels, Belgium Edegem, Belgium Gent, Belgium Leuven, Belgium Liège, Belgium Germany Berlin, Germany Hamburg, Germany Mainz, Germany Collapse << |
NCT02018536 | Healthy | Phase 1 | Completed | - | United States, California ... more >> Cypress, California, United States Collapse << |
NCT01424540 | Hepatitis C | Phase 1 | Completed | - | United States, New York ... more >> GSK Investigational Site Buffalo, New York, United States, 14202 Collapse << |
NCT01277692 | Hepatitis C | Phase 1 | Completed | - | United States, California ... more >> GSK Investigational Site Chula Vista, California, United States, 91911 United States, Kansas GSK Investigational Site Lenexa, Kansas, United States, 66219 United States, New Jersey GSK Investigational Site Willingboro, New Jersey, United States, 08046 Collapse << |
NCT01648140 | - | - | Completed | - | - |
NCT01827657 | Hepatitis C | Phase 1 | Completed | - | United States, Colorado ... more >> GSK Investigational Site Lakewood, Colorado, United States, 80228 United States, Florida GSK Investigational Site Orlando, Florida, United States, 32809 United States, Minnesota GSK Investigational Site Minneapolis, Minnesota, United States, 55404 United States, Tennessee GSK Investigational Site Knoxville, Tennessee, United States, 37920 Collapse << |
NCT01439373 | Hepatitis C, Chronic | Phase 2 | Completed | - | United States, California ... more >> GSK Investigational Site Anaheim, California, United States, 92801 GSK Investigational Site Chula Vista, California, United States, 91911 GSK Investigational Site Coronado, California, United States, 92118 GSK Investigational Site La Mesa, California, United States, 91942 GSK Investigational Site Oceanside, California, United States, 92056 United States, Florida GSK Investigational Site Miramar, Florida, United States, 33025 United States, Nevada GSK Investigational Site Las Vegas, Nevada, United States, 89109 United States, Oklahoma GSK Investigational Site Tulsa, Oklahoma, United States, 74104 United States, Texas GSK Investigational Site Houston, Texas, United States, 77004 Puerto Rico GSK Investigational Site San Juan, Puerto Rico, 00927 Collapse << |
NCT01648140 | Hepatitis C, Chronic | Phase 2 | Completed | - | - |
NCT01458054 | Hepatitis C | Phase 1 | Completed | - | United States, New York ... more >> GSK Investigational Site Buffalo, New York, United States, 14202 Collapse << |
NCT01439373 | - | - | Completed | - | - |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网